Figure 6

Correlation between the risk score and tumor microenvironment in the LUAD patients. (A–D) Comparison of immune scores, stromal scores, ESTIMATE scores and tumor purity between the high- and low-risk groups. (E) The abundance difference of 22 immune cells in the high- and low-risk groups. (F) Enrichment differences in immune function-related gene sets between high- and low-risk groups. (G) Heatmap of the TME score and immune gene expression of LUAD patients in different risk groups.